Pcn214 - Ibritumomab Tiuxetan Radiolabelled With Yttrium Chloride: 4 Years of Use in the 37 Public Hospitals of Paris and in France
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.296
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV